Skip to main content

Peer Review reports

From: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

Original Submission
17 Sep 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
27 Dec 2021 Reviewed Reviewer Report
8 Jan 2022 Reviewed Reviewer Report
9 Feb 2022 Author responded Author comments - Benjamin Chastek
Resubmission - Version 5
9 Feb 2022 Submitted Manuscript version 5
28 Feb 2022 Author responded Author comments - Benjamin Chastek
Resubmission - Version 6
28 Feb 2022 Submitted Manuscript version 6
8 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
8 Mar 2022 Editorially accepted
9 Apr 2022 Article published 10.1186/s12876-022-02215-y

You can find further information about peer review here.

Back to article page